LOREEV XR FDA approval date

The FDA approved LOREEV XR on 27 Aug 2021.

FDA approval date
27 Aug 2021

Drug identity has not yet been verified against registry records

Also recorded as LORAZEPAM

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2021-08-27DayLOREEV XRFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA214826", "applicant_as_listed_by_fda": "ALMATICA", "brand_names": ["LOREEV XR"], "active_ingredients": ["LORAZEPAM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20210827", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026